Cancer therapy
AssigneeTurbine Simulated Cell Technologies Limited
InventorsBoldizsar Frigyes ELEK, Magdolna DJUREC, Daniel VERES, Iván FEKETE, Dorottya LUKÁCS-NÉMETH, Dorina Viktória SIMON
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising an NEK1 inhibitor and uses thereof in the treatment of cancer.
Claims29
A pharmaceutical composition for use in the treatment of head and neck cancer, mantle cell lymphoma or melanoma, wherein the composition comprises an NEK1 inhibitor.
A pharmaceutical composition for use in the treatment of a cancer in a patient wherein the cancer exhibits a p53 mutation, wherein the composition comprises an NEK1 inhibitor.
(canceled)
(canceled)
(canceled)
(canceled)
A pharmaceutical composition comprising an NEK1 inhibitor and an ATM inhibitor.
Dependencies are inferred from the claim text.